BC

Birchview Capital Portfolio holdings

AUM $101M
This Quarter Return
-7.77%
1 Year Return
+34.62%
3 Year Return
+103.2%
5 Year Return
+107.72%
10 Year Return
+352.1%
AUM
$150M
AUM Growth
+$150M
Cap. Flow
+$2.02M
Cap. Flow %
1.35%
Top 10 Hldgs %
78.1%
Holding
51
New
–
Increased
6
Reduced
3
Closed
1

Top Buys

1
QDEL icon
QuidelOrtho
QDEL
$1.69M
2
BMY.RT
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
$1.12M
3
ACAD icon
Acadia Pharmaceuticals
ACAD
$371K
4
ALBO
Albireo Pharma, Inc. Common Stock
ALBO
$334K
5
AMRN
Amarin Corp
AMRN
$168K

Top Sells

1
GILD icon
Gilead Sciences
GILD
$769K
2
AWH
Aspira Women's Health Inc. Common Stock
AWH
$638K
3
NARI
Inari Medical, Inc. Common Stock
NARI
$207K
4
WKHS icon
Workhorse Group
WKHS
$177K

Sector Composition

1 Healthcare 95.26%
2 Energy 1.16%
3 Consumer Discretionary 0.13%
4 Consumer Staples 0.1%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
BMY icon
1
Bristol-Myers Squibb
BMY
$96B
$47.9M 32%
794,386
+2,000
+0.3% +$121K
AXDX
2
DELISTED
Accelerate Diagnostics
AXDX
$23.4M 15.62%
2,193,795
– –
QDEL icon
3
QuidelOrtho
QDEL
$1.95B
$12.9M 8.6%
58,644
+7,700
+15% +$1.69M
AWH
4
DELISTED
Aspira Women's Health Inc. Common Stock
AWH
$9.51M 6.36%
3,090,104
-207,143
-6% -$638K
NBIX icon
5
Neurocrine Biosciences
NBIX
$13.8B
$7.5M 5.01%
78,000
– –
ACAD icon
6
Acadia Pharmaceuticals
ACAD
$4.38B
$4.21M 2.81%
102,000
+9,000
+10% +$371K
BLUE
7
DELISTED
bluebird bio
BLUE
$3.24M 2.16%
60,000
– –
BIIB icon
8
Biogen
BIIB
$19.4B
$3.12M 2.08%
11,000
– –
BMY.RT
9
DELISTED
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
$2.72M 1.81%
1,206,848
+500,000
+71% +$1.12M
KPTI icon
10
Karyopharm Therapeutics
KPTI
$61.7M
$2.45M 1.64%
168,000
– –
XLRN
11
DELISTED
Acceleron Pharma Inc.
XLRN
$2.1M 1.4%
18,672
– –
SLNO icon
12
Soleno Therapeutics
SLNO
$3.6B
$2.08M 1.39%
826,899
– –
OXFD
13
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
$1.99M 1.33%
170,303
– –
ALBO
14
DELISTED
Albireo Pharma, Inc. Common Stock
ALBO
$1.94M 1.29%
58,000
+10,000
+21% +$334K
MASI icon
15
Masimo
MASI
$7.59B
$1.89M 1.26%
8,000
– –
UTHR icon
16
United Therapeutics
UTHR
$13.8B
$1.82M 1.21%
18,000
– –
ARNA
17
DELISTED
Arena Pharmaceuticals Inc
ARNA
$1.65M 1.1%
22,000
– –
CCXI
18
DELISTED
ChemoCentryx, Inc.
CCXI
$1.64M 1.1%
30,000
– –
MYOK
19
DELISTED
MyoKardia, Inc. Common Stock
MYOK
$1.36M 0.91%
10,000
– –
CFRX
20
DELISTED
ContraFect Corporation
CFRX
$1.35M 0.9%
255,700
– –
AMRN
21
Amarin Corp
AMRN
$311M
$1.26M 0.84%
300,000
+40,000
+15% +$168K
ETRN
22
DELISTED
Equitrans Midstream Corporation Common Stock
ETRN
$1.13M 0.75%
133,050
– –
HROW icon
23
Harrow
HROW
$1.44B
$1.01M 0.67%
180,000
– –
CORT icon
24
Corcept Therapeutics
CORT
$7.35B
$870K 0.58%
50,000
– –
EPZM
25
DELISTED
Epizyme, Inc
EPZM
$835K 0.56%
70,000
– –
1
2 3